Here we go again, the bubble fever is back! Here we go again, the bubble fever is back! Here we go again, the bubble fever is back!

Here we go again, the bubble fever is back!

Equities 5 minutes to read
Peter Garnry

Head of Equity Strategy

Key Points:

  • Strong start to the year: The S&P 500 is up 6.5%, nearly a year's worth of normal returns, driven by optimism and booming AI and obesity themes.

  • Concerns about overvaluation: Nvidia's recent success and high valuations in US equities raise concerns of a potential bubble similar to the dot-com era.

  • Negative real returns possible: Historically, similar valuation levels have led to negative real returns after accounting for inflation.

  • Recommendations for investors: Diversify away from US equities, consider bonds, European stocks, dividend stocks, or hedging strategies.

A year’s return in just two months

The equity market momentum has been incredible driven by the continuous realisation over the past year that a US economic recession was not coming and that certain sectors of the economy was in fact booming. This year alone the S&P 500 Index is up 6.5% including reinvestment of dividends, so almost an entire year of normal equity returns has been delivered to investors in just two months.

S&P 500 | Source: Saxo

With Nvidia’s extraordinary results and outlook last week captivating investors and their grandiose statement that generative AI has reached a “tipping point” might be exactly the signal that confirms that the equity market is getting too hot.

Last year we said that equity valuations were not a concern for global equities but US equities were getting increasingly stretched. However, when you have an AI hype then things can get really stretched and our view is now that we have entered a dangerous level again in US equities. As our valuation chart below shows, US equities are now significantly more expensive compared to the average valuation since 1992. In fact, US equities have now reached levels we have only observed during the dot-com bubble and the 2021 technology bubble during the pandemic.

If we take a look at the seven metrics going into the combined valuation metric then we can see that it is really the price-to-sales, EV-to-EBITDA, price-to-cash-flow, and EV-to-sales that are pushing US equities into overvaluation levels. The price investors are willing to pay for sales has been driven by technology companies increasingly dominating the US equity indices because US technology companies have a higher profit margin. The higher the profit margin the more investors are willing to pay for a dollar of revenue. This naturally leads to the conclusions that a lot of the current price level in US equities hinges on assumptions that US technology companies can maintain their abnormally high profit margin.

Could we really have a decade of negative real returns in equities?

Our discussion about US equity valuations become even more concerning when we take the equity valuation level today and go back in time to see what that level meant for future returns. The future returns we can lean on is those that came after the dot-com bubble, and here the picture is clear, when you get to these equity valuation levels future returns after subtracting inflation become negative. Can investors really expect that again this time?

The US equity market peaked in terms of equity valuation in December 2021 which was just before the big readjustment of equity valuations as interest rates began to ascent getting the point from the Fed that inflation was more entrenched that initially thought. We are now 26 months into this cycle of investing in US equities from an alarmingly high starting point in terms of valuation. Since December 2021, the S&P 500 Index has returned 2.4% annualised while US inflation has risen 5% annualised over the same period. So already a bit more than 20% into this new period of future returns from levels that even exceeded those during the dot-com bubble, we  are seeing equities falling behind delivering a negative annualised real return of 2.6%. It is our fiduciary responsibility as market professionals to warn investors about the current dynamics in US equities.

What should investors do?

For investors it means that it is probably a good idea to act on what we are seeing in the equity market. Our view is that it is always best to be invested so investors should increase their cash position, but instead think about how to diversify their portfolio to mitigate the valuation risk in US equities and in particular US technology stocks. Here are a couple of options to consider:

  • Reduce exposure to equities and increase exposure to bonds in order to reduce portfolio risk.

  • Reduce exposure to US equities and Increase exposure to European equities which have a less cyclical profile and lower equity valuation.

  • Increase exposure to dividend stocks as they will likely be less volatile should the equity market begin to reduce lower US equity valuations.
For those that have the long-term stocks they want, one could consider temporarily hedge their portfolio by selling a CFD on the S&P 500 or buy a put option on the S&P 500 (the at-the-money puts on S&P 500 with expiry on 20 December 2024 costs roughly 4%).

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.